HUP9600498A3 - Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same - Google Patents
Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the sameInfo
- Publication number
- HUP9600498A3 HUP9600498A3 HU9600498A HUP9600498A HUP9600498A3 HU P9600498 A3 HUP9600498 A3 HU P9600498A3 HU 9600498 A HU9600498 A HU 9600498A HU P9600498 A HUP9600498 A HU P9600498A HU P9600498 A3 HUP9600498 A3 HU P9600498A3
- Authority
- HU
- Hungary
- Prior art keywords
- pyrimidinylpiperazines
- antimigrane
- indolylalkyl
- pyridinyl
- pharmaceutical compositions
- Prior art date
Links
- 150000004868 1,2,5-thiadiazoles Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/396,825 US5618816A (en) | 1995-03-02 | 1995-03-02 | Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9600498D0 HU9600498D0 (en) | 1996-04-29 |
HUP9600498A2 HUP9600498A2 (en) | 1997-10-28 |
HUP9600498A3 true HUP9600498A3 (en) | 1998-10-28 |
Family
ID=23568771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9600498A HUP9600498A3 (en) | 1995-03-02 | 1996-02-29 | Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same |
Country Status (17)
Country | Link |
---|---|
US (1) | US5618816A (hu) |
EP (1) | EP0729958A2 (hu) |
JP (1) | JPH08253479A (hu) |
KR (1) | KR960034200A (hu) |
CN (1) | CN1063177C (hu) |
AR (1) | AR002281A1 (hu) |
AU (1) | AU707770B2 (hu) |
CA (1) | CA2169804A1 (hu) |
CZ (1) | CZ46896A3 (hu) |
HU (1) | HUP9600498A3 (hu) |
IL (1) | IL117224A (hu) |
NO (1) | NO305248B1 (hu) |
NZ (1) | NZ286090A (hu) |
PL (1) | PL313022A1 (hu) |
RU (1) | RU2165420C2 (hu) |
TW (1) | TW331558B (hu) |
ZA (1) | ZA961392B (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0759918A1 (en) * | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
GB9501865D0 (en) * | 1995-01-31 | 1995-03-22 | Merck Sharp & Dohme | Therapeutic agents |
US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
ATE546134T1 (de) * | 2002-12-26 | 2012-03-15 | Pozen Inc | Mehrschichtige dosierformen enthaltend naproxen und triptane |
KR20060015641A (ko) * | 2003-06-06 | 2006-02-17 | 글락소 그룹 리미티드 | 트립탄 및 nsaid를 포함하는 조성물 |
EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
WO2016192657A1 (en) | 2015-06-03 | 2016-12-08 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
FI76795C (fi) * | 1979-09-04 | 1988-12-12 | Bristol Myers Co | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter. |
US4600779A (en) * | 1982-03-29 | 1986-07-15 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
IT1170387B (it) * | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
US4440933A (en) * | 1983-03-16 | 1984-04-03 | Bristol-Myers Company | Process for preparing 1,2,5-thiadiazoles |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
US5077293A (en) * | 1990-06-29 | 1991-12-31 | Bristol-Myers Squibb Co. | 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
CA2043709C (en) * | 1990-06-29 | 2002-01-22 | David W. Smith | Antimigraine alkoxypyrimidine derivatives |
DE4101686A1 (de) * | 1991-01-22 | 1992-07-23 | Merck Patent Gmbh | Indolderivate |
CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
CA2130078A1 (en) * | 1993-09-16 | 1995-03-17 | Jonas A. Gylys | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |
EP0759918A1 (en) * | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
GB9410031D0 (en) * | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
-
1995
- 1995-03-02 US US08/396,825 patent/US5618816A/en not_active Expired - Lifetime
-
1996
- 1996-02-03 TW TW085101358A patent/TW331558B/zh active
- 1996-02-16 CZ CZ96468A patent/CZ46896A3/cs unknown
- 1996-02-19 CA CA002169804A patent/CA2169804A1/en not_active Abandoned
- 1996-02-21 ZA ZA9601392A patent/ZA961392B/xx unknown
- 1996-02-22 IL IL11722496A patent/IL117224A/xx not_active IP Right Cessation
- 1996-02-22 NO NO960699A patent/NO305248B1/no not_active IP Right Cessation
- 1996-02-28 NZ NZ286090A patent/NZ286090A/en unknown
- 1996-02-29 HU HU9600498A patent/HUP9600498A3/hu unknown
- 1996-02-29 KR KR1019960005354A patent/KR960034200A/ko not_active Application Discontinuation
- 1996-03-01 AU AU45819/96A patent/AU707770B2/en not_active Ceased
- 1996-03-01 EP EP96103214A patent/EP0729958A2/en not_active Ceased
- 1996-03-01 JP JP8044338A patent/JPH08253479A/ja active Pending
- 1996-03-01 CN CN96105542A patent/CN1063177C/zh not_active Expired - Fee Related
- 1996-03-01 AR ARP960101598A patent/AR002281A1/es unknown
- 1996-03-01 RU RU96103685/04A patent/RU2165420C2/ru not_active IP Right Cessation
- 1996-03-01 PL PL96313022A patent/PL313022A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU707770B2 (en) | 1999-07-22 |
EP0729958A2 (en) | 1996-09-04 |
NO305248B1 (no) | 1999-04-26 |
PL313022A1 (en) | 1996-09-16 |
NO960699D0 (no) | 1996-02-22 |
CA2169804A1 (en) | 1996-09-03 |
AU4581996A (en) | 1996-09-12 |
NO960699L (no) | 1996-09-03 |
CN1138042A (zh) | 1996-12-18 |
ZA961392B (en) | 1997-08-21 |
RU2165420C2 (ru) | 2001-04-20 |
HU9600498D0 (en) | 1996-04-29 |
AR002281A1 (es) | 1998-03-11 |
HUP9600498A2 (en) | 1997-10-28 |
JPH08253479A (ja) | 1996-10-01 |
EP0729958A3 (hu) | 1996-10-02 |
IL117224A (en) | 2000-06-29 |
TW331558B (en) | 1998-05-11 |
CN1063177C (zh) | 2001-03-14 |
US5618816A (en) | 1997-04-08 |
KR960034200A (ko) | 1996-10-22 |
CZ46896A3 (en) | 1996-09-11 |
IL117224A0 (en) | 1996-06-18 |
NZ286090A (en) | 1997-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0000474A3 (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
IL116917A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
ZA94342B (en) | C2 Taxane derivatives and pharmaceutical compositions containing them | |
IL109316A0 (en) | 1, 5-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them | |
IL106927A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
IL117962A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
HU9403491D0 (en) | Thiazolidine derivatives and pharmaceutical composition containing the same | |
HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
AU6613996A (en) | Heterocyclic compounds and pharmaceutical compositions containing them | |
IL106904A0 (en) | Thiazolidine derivatives,their preparation and pharmaceutical compositions containing them | |
IL104447A0 (en) | 1,5-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL110988A0 (en) | 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same | |
PH30439A (en) | 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same | |
GB2271059B (en) | Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives. | |
HUP9801356A3 (en) | Triciclic (2-hydroxy-2-methyl-3,3,3-trifluoropropanoyl)-amino-benzoxepine, -benzothiepine, -benzocycloheptene, -indene derivatives and pharmaceutical compositions containing them | |
HUT73499A (en) | 1,5-benzodiazepine derivatives and pharmaceutical compositions containing them | |
HUP9602196A2 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
AU678208B2 (en) | 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them | |
HUP9600498A3 (en) | Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same | |
IL110809A0 (en) | 1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them | |
HUP9903526A3 (en) | Pyrimidine derivatives and pharmaceutical compositions containing the same | |
IL106549A0 (en) | Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them |